For the first quarter of 2021 NPO Microgen, managed by the Nacimbio holding of the Rostec State Corporation, has increased the export of medicinal products to Uzbekistan by more than one and a half times compared to the same period last year. By volume, about 500 thousand packages of medicines have been exported to the republic.
The medicines of the pharmacological group of bacteriophages, registered in the country in 2019, turned to be the key sales driver. Their ratio was about 40% of total sales. Sextafag, supplied to Uzbekistan since 2018, was in the highest demand. In the first quarter of this year alone, its sales to the republic exceeded the total annual sales volume of the drug in 2020 by 60%. Sextafag has a broad spectrum of antimicrobial action and is designed for the treatment and prevention of pyoinflammatory and enteric diseases caused by staphylococci, streptococci, Proteus mirabilis, Klebsiella, Pseudomonas, and E. coli.
Moreover, wholesale supplies to the republic of two types of bacteriophages (Intesti and Staphylococcus bacteriophage) were arranged for the first time. For the Staphylococcus bacteriophage a new, more convenient dosage form of 20 ml was registered in Uzbekistan last year.
The Republic of Uzbekistan is Microgen’s strategic partner. Thanks to effective cooperation with local pharmaceutical distributors, supported by the state, the company managed to increase both the list and the volume of products supplied to the republic over the past three years. “Currently, we ship to Uzbekistan about 40 names of medicinal products, including such pharmacological groups as bacteriophages, vaccines and anatoxins, as well as finished medicinal products used for treatment of socially significant diseases, such as cardiovascular diseases and many others,” said Andrey Zagorskiy , General Director of Nacimbio, the management company of Microgen.
Along with bacteriophages, in 2021 a wholesale quantity of the Russian botulinum toxin type A was exported to Uzbekistan for the first time, while supplies of allergens used for treatment and prevention of allergic diseases were resumed.